Longeveron Inc. Files 8-K Reporting Other Events
Ticker: LGVN · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1721484
Sentiment: neutral
Topics: regulatory-filing, 8-k, financial-statements
TL;DR
Longeveron filed an 8-K on July 9th for events on July 8th. Check for details.
AI Summary
Longeveron Inc. filed an 8-K on July 9, 2025, reporting other events and financial statements as of July 8, 2025. The company, incorporated in Delaware, is based in Miami, Florida, and operates in the pharmaceutical preparations sector. This filing does not detail specific transactions or financial figures but serves as a notification of events and accompanying exhibits.
Why It Matters
This 8-K filing indicates that Longeveron Inc. is making a regulatory disclosure regarding events and financial statements, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and exhibits, without immediate disclosure of significant financial changes or corporate actions.
Key Players & Entities
- Longeveron Inc. (company) — Registrant
- July 8, 2025 (date) — Date of earliest event reported
- July 9, 2025 (date) — Date of report
- Miami, Florida (location) — Principal Executive Offices
- Delaware (location) — State of Incorporation
FAQ
What specific 'Other Events' are being reported by Longeveron Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events'; it only indicates that this item is being reported.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported in this 8-K filing occurred on July 8, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on July 9, 2025.
Where are Longeveron Inc.'s principal executive offices located?
Longeveron Inc.'s principal executive offices are located at 1951 NW 7th Avenue, Suite 520, Miami, Florida 33136.
What is Longeveron Inc.'s Standard Industrial Classification (SIC) code?
Longeveron Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding Longeveron Inc. (LGVN).